Hyperfine, Inc.

Healthcare

NASDAQ:HYPR · NASDAQ Global Market

Market Cap $114.53M Beta 1.38 P/E (TTM) -3.8

$1.36 -4.23%

-$0.06 today

52W Low $0.66High $2.22

Vol 0.46M · Avg 0.61M

EPS (TTM)-$0.36

Medical - Devices

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+88.37%

Period High

$2.20

Period Low

$0.69

Latest

$1.36

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Edap Tms S.a.

EDAP

$178.23M

Quipt Home Medical Corp.

QIPT

$162.30M

Connect Biopharma Holdings Limited

NASDAQ:CNTB

$133.48M

FONAR Corporation

NASDAQ:FONR

$117.76M

AVITA Medical, Inc.

NASDAQ:RCEL

$97.14M

Vivani Medical, Inc.

NASDAQ:VANI

$64.99M

ImageneBio Inc

NASDAQ:IMA

$63.39M

Pulmonx Corporation

NASDAQ:LUNG

$57.86M

InspireMD, Inc.

NSPR

$34.19M

Quince Therapeutics, Inc.

QNCX

$5.20M

What is the latest HYPR filing?

The latest filing shown is 4 dated Jun 4, 2026.

How many recent filings does HYPR have?

Intrinsic Alpha currently shows 20 recent filings for HYPR.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.